PPARG and dysautonomia: The present post mortem study in a rhesus monkey model of PD cardiac dysautonomia aimed to validate in vivo cardiac PET markers of sympathetic innervation, oxidative stress and inflammation and evaluate PPARγ target engagement by pioglitazone.